Effects of Coenzyme Q10 Supplementation on Serum Values of Gamma-glutamyl transferase, Pseudocholinesterase, Bilirubin, Ferritin, and High-Sensitivity C-Reactive Protein in Women with Type 2 Diabetes.


Journal

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
ISSN: 1439-3646
Titre abrégé: Exp Clin Endocrinol Diabetes
Pays: Germany
ID NLM: 9505926

Informations de publication

Date de publication:
May 2019
Historique:
pubmed: 25 1 2018
medline: 3 9 2019
entrez: 25 1 2018
Statut: ppublish

Résumé

Type 2 diabetes mellitus (T2DM) is a disease associated with increased oxidative stress which results from mitochondrial dysfunction. Coenzyme Q Eighty women with T2DM enrolled in this study. Thirty six of them were randomized in the drug group (receiving 100 mg/day of CoQ Serum values of FBS (P=0.039), HOMA-IR (P=0.01), ferritin (P<0.001), total cholesterol (TC) (P=0.006), LDL-C (P=0.007) decreased and HDL-C (P=0.02) increased significantly in the drug group after intervention. Serum levels of triglyceride (P=0.09) decreased marginally in CoQ The results of the current study had shown that after supplementation with 100 mg/day of CoQ

Sections du résumé

BACKGROUND BACKGROUND
Type 2 diabetes mellitus (T2DM) is a disease associated with increased oxidative stress which results from mitochondrial dysfunction. Coenzyme Q
MATERIAL & METHODS METHODS
Eighty women with T2DM enrolled in this study. Thirty six of them were randomized in the drug group (receiving 100 mg/day of CoQ
RESULTS RESULTS
Serum values of FBS (P=0.039), HOMA-IR (P=0.01), ferritin (P<0.001), total cholesterol (TC) (P=0.006), LDL-C (P=0.007) decreased and HDL-C (P=0.02) increased significantly in the drug group after intervention. Serum levels of triglyceride (P=0.09) decreased marginally in CoQ
CONCLUSIONS CONCLUSIONS
The results of the current study had shown that after supplementation with 100 mg/day of CoQ

Identifiants

pubmed: 29365333
doi: 10.1055/s-0043-124183
doi:

Substances chimiques

Blood Glucose 0
Cholesterol, HDL 0
Cholesterol, LDL 0
Ubiquinone 1339-63-5
C-Reactive Protein 9007-41-4
Ferritins 9007-73-2
gamma-Glutamyltransferase EC 2.3.2.2
Butyrylcholinesterase EC 3.1.1.8
coenzyme Q10 EJ27X76M46
Bilirubin RFM9X3LJ49

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

311-319

Informations de copyright

© Georg Thieme Verlag KG Stuttgart · New York.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to declare.

Auteurs

Mahsa Gholami (M)

Student Research Committee, Arak University of Medical Sciences, Arak, Iran.

Mohammad Reza Rezvanfar (MR)

Department of Internal Medicine, School of Medicine, Arak University of Medical Sciences, Arak, Iran.

Mostafa Delavar (M)

Department of Pharmacology, School of Medicine, Arak University of Medical Sciences, Arak, Iran.

Mahdi Abdollahi (M)

Expert of Control Laboratory Food and Beverage, Decorative, Hygienic Products of Arak's Medical Sciences University, Arak University of Medical Sciences, Arak, Iran.

Ali Khosrowbeygi (A)

Department of Biochemistry and Genetics, School of Medicine, Arak University of Medical Sciences, Arak, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH